Australian Clinical Labs Limited
ACL.AX
Price:
$2.27
Market Cap:
$423.40M
Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial dr...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-05-14
Stock Exchange
ASX
Ticker
ACL.AX
PE Ratio
[16.21]
ROE
[16.35%]
Current Ratio
[0.59]
Dividend Yield
[5.62%]
Enterprise Value
[854.57M]
Dividend History
ACL.AX Dividend History Overview
Dividends are a key part of long-term returns for investors, and Australian Clinical Labs Limited (ACL.AX) has a track record worth reviewing. Looking at dividend history for ACL.AX gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-03-11
Dividend Yield
5.62%
Annual Dividend
$0.04
P/E Ratio
16.21
Payout Ratio
0.93
Dividend per Share
$0.13
EPS
0.14
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-03-11 | $0.0375 | $0.0375 | 2026-03-31 | |
| 2025-09-01 | $0.09 | $0.09 | 2025-09-23 | |
| 2025-03-26 | $0.035 | $0.035 | 2025-04-16 | 2025-03-28 |
| 2024-09-04 | $0.09 | $0.09 | 2024-09-27 | 2024-09-05 |
| 2024-03-28 | $0.03 | $0.03 | 2024-04-26 | |
| 2023-09-14 | $0.07 | $0.07 | 2023-10-03 | |
| 2023-03-27 | $0.07 | $0.07 | 2023-04-26 | |
| 2022-08-23 | $0.41 | $0.41 | 2022-09-15 | |
| 2022-03-25 | $0.12 | $0.12 | 2022-04-21 |
Australian Clinical Labs Limited (ACL.AX) Dividend History Chart
The table below shows Australian Clinical Labs Limited (ACL.AX) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Australian Clinical Labs Limited (ACL.AX) Dividend Growth
Australian Clinical Labs Limited (ACL.AX) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Clinuvel Pharmaceuticals Limited (CUV.AX) | 0.01% |
| Cogstate Limited (CGS.AX) | 0.01% |
| Monash IVF Group Limited (MVF.AX) | 0.06% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Australian Clinical Labs Limited (ACL.AX) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is ACL.AX’s dividend yield?
What is the difference between regular and special dividends?
Has ACL.AX increased its dividends over time?
Why might dividend history data be delayed?
How often does ACL.AX pay dividends?
What factors impact ACL.AX's dividend payments?
Can dividends change over time?
What is ACL.AX’s next dividend date?